Full investment portfolio of the Relevant Investments as at 30 June 2021
| Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
| NANFUN 4 ½ 09/20/22 EMTN | Bond | Singapore Exchange | BVI | USD | HK$9,797,000 | HK$9,631,000 | 0.0136% | BBB- / Baa3 / - |
| NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,602,000 | HK$57,238,000 | 0.0807% | BBB- / Baa3 / - |
| HKTGHD 3 ¾ 03/08/23 | Bond | Singapore Exchange | BVI | USD | HK$49,641,000 | HK$51,093,000 | 0.0720% | BBB / Baa2 / - |
| CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$36,768,000 | 0.0518% | B / B2 / BB |
| MOLAND 11 ½ 11/13/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$3,809,000 | HK$3,740,000 | 0.0053% | - / B3 / B |
| GRNCH 5.65 07/13/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$9,300,000 | HK$9,664,000 | 0.0136% | - / Ba3 / - |
| CIFIHG 5.95 10/20/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$77,488,000 | HK$82,212,000 | 0.1159% | BB- / - / BB |
| CAPG 4.2 01/20/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$29,945,000 | HK$29,440,000 | 0.0415% | - / - / - |
| ZHPRHK 5.95 11/18/21 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$38,772,000 | HK$38,935,000 | 0.0549% | - / - / - |
| CAPG 4 ¾ 09/01/21 | Bond | Unlisted | Cayman Islands | USD | HK$232,509,000 | HK$232,890,000 | 0.3283% | - / - / - |
| AGILE 4 ¼ 11/01/21 | Bond | Unlisted | Cayman Islands | USD | HK$542,521,000 | HK$548,627,000 | 0.7734% | - / - / - |
| KWGPRO 4 ⅜ 12/29/21 | Bond | Unlisted | Cayman Islands | USD | HK$775,350,000 | HK$794,155,000 | 1.1195% | - / - / - |
| EC Healthcare (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$54,354,000 | HK$180,123,000 | 0.2539% | N/A |
| Total | HK$1,918,837,000 | HK$2,074,516,000 | 2.9244% | |||||